HomeCompareSWRL vs JNJ

SWRL vs JNJ: Dividend Comparison 2026

SWRL yields 400000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SWRL wins by $5.011119029548644e+32M in total portfolio value
10 years
SWRL
SWRL
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full SWRL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SWRL vs JNJ

📍 SWRL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSWRLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SWRL + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SWRL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SWRL
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SWRL beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SWRL + JNJ for your $10,000?

SWRL: 50%JNJ: 50%
100% JNJ50/50100% SWRL
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SWRL
No analyst data
Altman Z
-0.9
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SWRL buys
0
JNJ buys
0
No recent congressional trades found for SWRL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSWRLJNJ
Forward yield400000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$5.011119029548644e+32M$20.0K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$827.78
Total dividends collected$5.010957816668433e+32M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SWRL vs JNJ ($10,000, DRIP)

YearSWRL PortfolioSWRL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$40,010,700$40,000,000.00$10,676$355.77+$40.00MSWRL
2$149,615,521,729$149,572,710,280.37$11,407$389.39+$149615.51MSWRL
3$522,880,052,725,200$522,719,964,116,949.25$12,198$426.53+$522880052.71MSWRL
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$13,056$467.62+$1707862989289.03MSWRL
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$13,987$513.12+$5213509402845684.00MSWRL
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$14,998$563.56+$14874219058409543680.00MSWRL
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$16,098$619.52+$3.966119623405075e+22MSWRL
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$17,295$681.69+$9.88384363503273e+25MSWRL
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$18,599$750.82+$2.302052364743449e+29MSWRL
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$20,022$827.78+$5.011119029548644e+32MSWRL

SWRL vs JNJ: Complete Analysis 2026

SWRLStock

U-Swirl, Inc., together with its subsidiaries, operates and franchises self-serve frozen yogurt cafés. It operates and franchises frozen yogurt cafés under the U-SWIRL Frozen Yogurt, CherryBerry, Yogurtini, Fuzzy Peach, Aspen Leaf Yogurt, Yogli Mogli, Let's Yo!, and Josie's Frozen Yogurt brand names. The company's cafés offer frozen yogurt in non-fat and low-fat flavors and with approximately 70 toppings. As of April 30, 2015, the company and its franchisees operated 259 self-serve frozen yogurt cafés in 37 states in the United States; and 4 foreign countries. U-Swirl, Inc. was incorporated in 2005 and is headquartered in Durango, Colorado.

Full SWRL Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SWRL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SWRL vs SCHDSWRL vs JEPISWRL vs OSWRL vs KOSWRL vs MAINSWRL vs ABBVSWRL vs MRKSWRL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.